Lilly gets USFDA nod for Taltz(ixekizumab) for Pediatric Patients with Moderate to Severe Plaque Psoriasis Medical Dialogues Bureau1 April 2020 12:30 PM ISTIndianapolis: Eli Lilly and Company have announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License...
Eli Lilly delays its clinical trials during Coronavirus pandemic Medical Dialogues Bureau25 March 2020 3:00 PM ISTIndianapolis: Eli Lilly and Company has provided an update on the company's clinical trial activities in light of the COVID-19 pandemic. The company...
Lilly Receives FDA Breakthrough Therapy Designation for Baricitinib for Alopecia Areata Medical Dialogues Bureau19 March 2020 12:56 PM ISTBaricitinib is currently approved for the treatment of adults with moderately to severely active rheumatoid arthritis (RA).
AbCellera, Eli Lilly join hands for Antibody Therapies for COVID-19 Medical Dialogues Bureau13 March 2020 9:00 AM ISTVancouver and Indianapolis: AbCellera and Eli Lilly and Company have recently announced that they have entered into an agreement to co-develop...
USFDA accepts regulatory submission for tanezumab for management of chronic pain due to osteoarthritis Medical Dialogues Bureau7 March 2020 10:00 AM ISTTanezumab is a monoclonal antibody that is part of an investigational class of non-opioid chronic pain medications known as nerve growth factor (NGF)...
FDA Advisory approves Lilly's CYRAMZA (ramucirumab) for type of lung Cancer Medical Dialogues Bureau1 March 2020 2:00 PM ISTThe ODAC considered the safety and efficacy data from the Phase 3 RELAY trial, which is the basis for the CYRAMZA supplemental Biologics License...
USFDA approves Eli Lilly's Trulicity (dulaglutide) for reduction in MACE in type 2 diabetes patient Medical Dialogues Bureau23 Feb 2020 12:00 PM ISTNew indication reflects a distinct patient population in the REWIND study, including primary people with multiple cardiovascular risk factors but...
Top Cos in pharmaceutical supply chain develop Blockchain system to track prescription drugs, stop counterfeit Medical Dialogues Bureau22 Feb 2020 4:04 PM ISTAmong the 24 participating companies are Amgen Inc, FedEx Corp, GlaxoSmithKline Plc, Novartis, AmerisourceBergen Corp , Sanofi ), Walgreens Boots...
Eli Lilly Completes Acquisition of Dermira Medical Dialogues Bureau22 Feb 2020 9:45 AM IST INDIANAPOLIS : Eli Lilly and Company has announced the successful completion of its acquisition of Dermira, Inc. (NASDAQ: DERM). The acquisition...
Eli Lilly to provide Migraine drug Reyvow Farhat Nasim4 Feb 2020 9:00 AM ISTNew Delhi: Eli Lilly and Company announced recently that REYVOW (lasmiditan) C-V 50 mg and 100 mg tablets, an oral medication for the acute treatment...
Eli Lilly new insulin to improve glycemic control in diabetics get positive opinion from EMA Farhat Nasim3 Feb 2020 3:03 PM ISTThe CHMP opinion is now referred for final action to the European Commission, which grants approval in the European Union. Lilly plans to market the...
Drugmajors slash prices by 53pc for China bulk-buy program eligibility Medical Dialogues Bureau20 Jan 2020 10:00 AM ISTBeijing: Global pharmaceutical majors and generic drugmakers chopped by 53% on average prices of some of their off-patent products in the latest...
